Dr Marek Tyl


Marek is a scientist, manager and a technology commercialisation strategist. He completed his PhD at the Department of Biochemistry, University of Cambridge working with Professor Ernest Laue on structural aspects of chromatin assembly. His research interests are focused on epigenetics in stem cell and cancer biology, drug discovery and the development of biological tools for epigenetic therapy. He was a Post-doctoral Research Fellow at Imperial College London working on biochemical characterisation of novel chromatin-associated factors and their role in cancer.

He has extensive experience working on technology strategy, landscaping and due-diligence projects for large and mid-size pharmaceutical companies. He has over 8 years of experience in R&D in the areas of protein biochemistry and molecular biology and has advised proof of concept level biotechnology startups. He is the founder and CEO of the Innovation Forum a leading global network of early-stage innovative companies and founder of Cambridge Squared - a technology scouting & strategy consultancy.

Other team Members


View profile

Dr Wen Hwa Lee

View profile

Aylin Luck

View profile

Dr Barbara Domayne-Hayman

Industry Advisory Board Member

View profile

Dr Claire Brown

View profile
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.